Effect of gonadotropin-releasing hormone analogue treatment in improving final adult height of children with central precocious puberty or early and fast puberty: a Meta analysis.
10.7499/j.issn.1008-8830.2108078
- Author:
Zhao-Le CHU
1
;
Hui JIANG
1
;
Qian WU
1
Author Information
1. Department of Pediatrics, Tongcheng People's Hospital of Anhui Province, Tongcheng, Anhui 231400, China.
- Publication Type:Meta-Analysis
- Keywords:
Central precocious puberty;
Child;
Early and fast puberty;
Final adult height;
Gonadotropin-releasing hormone analogue;
Meta analysis
- MeSH:
Adult;
Body Height;
Child;
Gonadotropin-Releasing Hormone;
Humans;
Puberty;
Puberty, Precocious/drug therapy*
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(11):1161-1168
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:To systematically evaluate the effect of gonadotropin-releasing hormone analogue (GnRHa) treatment on the final adult height of children over 6 years of age with central precocious puberty (CPP) or early and fast puberty (EFP).
METHODS:PubMed, MEDLINE, Embase, Cochrane Library, CNKI, and Wanfang Data were searched for related articles on GnRHa treatment for children with CPP or EFP. Stata 12.0 software was used to perform a Meta analysis of related data.
RESULTS:A total of 10 studies were included, and the total sample size was 720 children, with 475 children in the GnRHa treatment group and 245 children in the control group. The Meta analysis showed that compared with the control group, the GnRHa treatment group had significantly better final adult height (
CONCLUSIONS:GnRHa treatment is safe and effective in improving the final adult height of children over 6 years of age with CPP or EFP.
